Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Why cord blood?

Pablo Rubinstein1

  • 1National Cord Blood Program, Milstein Cord Blood Center, New York Blood Center, NY, USA.

Human Immunology
|May 27, 2006
PubMed
Summary
This summary is machine-generated.

Cord blood stem cell transplants have advanced significantly since 1988. Large, diverse cord blood banks are crucial for improving HLA matching and long-term survival rates in patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The wider perspective: cord blood banks and their future prospects.

British journal of haematology·2021
Same author

[Recommendations for performing interventions during the COVID-19 pandemic].

Revista medica de Chile·2021
Same author

Impact of delayed umbilical cord clamping on public cord blood donations: can we help future patients and benefit infant donors?

Transfusion·2018
Same author

Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.

Transfusion·2017
Same author

Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.

PloS one·2015
Same author

Low Molecular Weight Fraction of Commercial Human Serum Albumin Induces Morphologic and Transcriptional Changes of Bone Marrow-Derived Mesenchymal Stem Cells.

Stem cells translational medicine·2015

Area of Science:

  • Hematology
  • Transplantation immunology
  • Regenerative medicine

Background:

  • Cord blood is an established source for hematopoietic stem cell transplantation (HSCT) for related and unrelated donors.
  • Over 7,000 unrelated-donor cord blood transplants have been performed globally since 1993.
  • The use of cord blood for HSCT began with the discovery of colony-forming cells in 1974.

Purpose of the Study:

  • To review the history and development of cord blood banking.
  • To discuss critical factors influencing transplant success.
  • To highlight the need for expanded cord blood inventories.

Main Methods:

  • Review of historical data and scientific literature on cord blood transplantation.
  • Analysis of key variables affecting transplant outcomes.

Related Experiment Videos

  • Discussion of cord blood banking strategies.

    • Main Results:

    • Cord blood transplantation has evolved significantly since the first successful procedure in 1988.
    • Hematopoietic stem cell dose and Human Leukocyte Antigen (HLA) match grade are critical for long-term survival.
    • Mismatched cord blood transplants generally result in milder graft-versus-host disease.

    Conclusions:

    • Effective cord blood banking requires large and ethnically diverse inventories.
    • Improved HLA matching through expanded banks enhances long-term recipient survival.
    • Continued development of cord blood banking systems is essential for advancing HSCT.